Press releases
- Press releases
- Browse
Press releases
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
AMARIN REPORTS INITIATION OF ENROLLMENT AND FIRST PATIENT DOSING IN PIVOTAL PHASE III CLINICAL TRIALS FOR MIRAXION IN HUNTINGTON'S DISEASE More
Amarin announces results from pre-clinical research conducted at Trinity College, Dublin More
2005 Third quarter financial results and corporate developments. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2008 - 120 pages - $1,040
Jan 2009 - $15,200
Sep 2010 - 412 pages - $1,040
Nov 2010 - 7 pages - $500
Jan 2010 - $15,200
May 2011 - 23 pages - $125
May 2011 - 43 pages - $500
Nov 2010 - 40 pages - $500
Aug 2008 - 352 pages - $2,615
Dec 2010 - 36 pages - $500
Your selection
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Acute coronary syndromes
- Anemia
- Anticoagulants
- Blood clotting
- Blood composition
- Cardiovascular disorder (other)
- Cerebrovascular disorders
- Thrombotic disorders
- Treatments
- Vascular
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us